2017-67-6 Usage
General Description
2-(2-Naphthyl)ethylamine hydrochloride is a chemical compound with the formula C12H13N·HCl. It is a salt form of 2-(2-Naphthyl)ethylamine, an organic compound containing a naphthalene ring and an ethylamine group. 2-(2-NAPHTHYL)ETHYLAMINE HYDROCHLORIDE is commonly used as a reagent in the synthesis of various pharmaceutical and organic compounds. It is also used as an intermediate in the production of dyes, pigments, and other organic materials. Its hydrochloride form increases its solubility in water, making it easier to handle and use in various chemical reactions and processes. Additionally, it is important to handle this chemical with care, as it may be harmful if ingested, inhaled, or in contact with skin.
Check Digit Verification of cas no
The CAS Registry Mumber 2017-67-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,1 and 7 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2017-67:
(6*2)+(5*0)+(4*1)+(3*7)+(2*6)+(1*7)=56
56 % 10 = 6
So 2017-67-6 is a valid CAS Registry Number.
2017-67-6Relevant articles and documents
Novel compounds and compositions for treating diseases asociated with protease activity
-
, (2008/06/13)
Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.
